PhotoMedex, Inc. (NASDAQ: PHMD) provides novel solutions designed for application in the areas of dermatology, therapeutic skin care and surgical products & services. The company is currently developing proprietary excimer laser and fiber-optic systems to treat dermatological applications such as psoriasis and vitiligo. PhotoMedex’s XTRAC® was the first FDA market-cleared excimer laser system designed to treat dermatological applications such as psoriasis and vitiligo. For further information, visit the Company’s web site at www.photomedex.com.
- 18 years ago
QualityStocks
PhotoMedex, Inc. (NASDAQ: PHMD)
Tags Rodman & Renshaw
Related Post
-
Wild Gold Discovery Drill Holes with Gold Over 200 Meters Intercepts at Lafleur Minerals (CSE: LFLR) (OTCQB: LFLRF) Swanson Gold Deposit Point Towards a District-Scale Gold Discovery
Disseminated on behalf of LaFleur Minerals Inc. (CSE: LFLR) (OTCQB: LFLRF)and may include paid advertising.…
-
HeartBeam Inc. (NASDAQ: BEAT) Tackles Heart Disease with Next-Generation ECG Solutions
Cardiovascular disease remains the leading cause of death in the United States. One of the…
-
Planet Ventures Inc. (CSE: PXI) (OTC: PNXPF) Positions for Next Phase of Commercial Space Infrastructure Expansion
Disseminated on behalf of Planet Ventures Inc. (CSE: PXI) (OTC: PNXPF) and may include paid advertising.…